We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

329 hedge funds and large institutions have $1.25B invested in Takeda Pharmaceutical in 2025 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 134 increasing their positions, 77 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,201% more call options, than puts

Call options by funds: $25.3M | Put options by funds: $1.95M

74% more repeat investments, than reductions

Existing positions increased: 134 | Existing positions reduced: 77

41% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 41

4% more funds holding

Funds holding: 315 → 329 (+14)

4% more capital invested

Capital invested by funds: $1.2B → $1.25B (+$44.2M)

0.23% more ownership

Funds ownership: 2.45% → 2.68% (+0.23%)

Holders
329
Holders Change
+14
Holders Change %
+4.44%
% of All Funds
4.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
58
Increased
134
Reduced
77
Closed
41
Calls
$25.3M
Puts
$1.95M
Net Calls
+$23.4M
Net Calls Change
-$3.02M

Top Buyers

Rank Fund Capital Flow
1
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$44.6M
2
UBS Group
UBS Group
Switzerland
+$27.8M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$23.9M
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$21.2M
5
AA
ABC Arbitrage
France
+$8.49M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$39.2M
2
Bank of America
Bank of America
North Carolina
-$9.93M
3
Millennium Management
Millennium Management
New York
-$7.91M
4
Verition Fund Management
Verition Fund Management
Connecticut
-$6.14M
5
BlackRock
BlackRock
New York
-$3.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
276
Geneos Wealth Management
Colorado
$4.49K -$28.2K -1,901 -86%
AIC
277
Archer Investment Corporation
Indiana
$4.35K – – –
BIA
278
Bell Investment Advisors
California
$4.1K – – –
APW
279
Atlantic Private Wealth
North Carolina
$4.03K +$4.08K +275 New
HWP
280
Highline Wealth Partners
California
$3.97K – – –
RWS
281
Retirement Wealth Solutions
Wisconsin
$3.85K +$3.91K +263 New
CTB
282
Country Trust Bank
Illinois
$3.79K +$3.85K +259 New
IAS
283
IMA Advisory Services
Colorado
$3.76K – – –
TPCW
284
TD Private Client Wealth
New York
$3.7K – – –
KFA
285
Kelleher Financial Advisors
New York
$3.67K +$3.73K +251 New
HAP
286
Harbor Asset Planning
Massachusetts
$3.44K – – –
PP
287
PFS Partners
New Jersey
$3.32K – – –
CMP
288
Coston McIsaac & Partners
Maine
$3K – – –
Nisa Investment Advisors
289
Nisa Investment Advisors
Missouri
$2.93K – – –
BSB
290
Bangor Savings Bank
Maine
$2.72K – – –
EPIM
291
Evelyn Partners Investment Management
$2.44K – – –
PWA
292
Physician Wealth Advisors
Utah
$2.23K +$653 +44 +41%
APW
293
Aventura Private Wealth
Florida
$2.18K – – –
MWA
294
Medallion Wealth Advisors
Connecticut
$2.05K – – –
HFS
295
Hughes Financial Services
Virginia
$1.99K – – –
T
296
Tidemark
California
$1.84K – – –
FMP
297
Financial Management Professionals
Texas
$1.83K – – –
SIS
298
Strategic Investment Solutions
Illinois
$1.83K – – –
TCM
299
Tradewinds Capital Management
Washington
$1.74K +$1.77K +119 New
MG
300
Mather Group
Illinois
$1.52K +$1.54K +104 New
10 11
12
13 14

TAK Hedge Fund Activity: Q3 2025 in Review

329 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q3 2025, worth a combined $1.25B — up 3.7% from $1.2B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new TAK positions and 41 closed out — a net gain of 17 holders — while 134 added to existing stakes and 77 trimmed.

The largest buyer was Toronto Dominion Bank, opening a new position worth an estimated $44.6M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $39.2M sold.

  • 329 institutional investors held Takeda Pharmaceutical (TAK) as of Q3 2025, up from 315 in Q2 2025.
  • Funds reported $1.25B of Takeda Pharmaceutical stock for Q3 2025, up 3.7% quarter-over-quarter.
  • 58 funds opened new Takeda Pharmaceutical positions in Q3 2025 and 41 closed out, a net change of +17 holders.
  • The largest Takeda Pharmaceutical buyer in Q3 2025 was Toronto Dominion Bank, an estimated $44.6M added.
  • The largest Takeda Pharmaceutical seller in Q3 2025 was Adage Capital Partners, an estimated $39.2M sold.

Based on aggregated 13F filings for Q3 2025.